- Substance: Mazdutide
- Concentration: 10 mg/ml
- Form: Injectable vial
- Dosage: 3–9 mg/week (men and women)
- Manufacturer: Dragon Pharma
- Brand Name: Mazdutide
SKU: P3854
Shipping From
Mazdutide by Dragon Pharma is a cutting-edge dual GLP-1 and glucagon receptor agonist delivered in a vial containing 10 mg/ml. Designed to tackle obesity, insulin resistance, and energy dysregulation, Mazdutide promotes significant fat loss, improves glucose control, and enhances metabolic health, making it a game-changer for bodybuilders and health-conscious individuals seeking a lean, energized physique. Its long-acting, once-weekly injection offers convenience and efficacy.
What It Is
Mazdutide, also known as IBI362 or LY3305677, is a synthetic peptide analog of oxyntomodulin, a gut hormone. As a dual agonist, it activates both GLP-1 and glucagon receptors, targeting appetite regulation, glucose metabolism, and energy expenditure. Originally developed by Eli Lilly and licensed to Innovent Biologics, it's under phase 3 clinical trials for obesity and type 2 diabetes, offering superior bioavailability via injection compared to oral alternatives.
How It Works
Mazdutide activates GLP-1 receptors in the pancreas, brain, and digestive system, enhancing insulin secretion, delaying gastric emptying, and suppressing appetite for reduced calorie intake. Simultaneously, it stimulates glucagon receptors to increase energy expenditure via fat breakdown and thermogenesis, converting white fat into metabolically active beige fat. Its half-life of several days allows for once-weekly dosing, ensuring sustained effects. Detection times are not well-documented due to its investigational status.
Benefits
- Significant Fat Loss: Up to 15.4% body weight reduction in 24 weeks, ideal for cutting phases.
- Glycemic Control: Lowers HbA1c by up to 1.7%, supporting insulin sensitivity.
- Metabolic Boost: Enhances energy expenditure and fat oxidation for a leaner physique.
- Cardiometabolic Health: Improves blood pressure, lipid profiles, and liver fat content.
- Convenient Dosing: Once-weekly injection for ease of use.
Who It's For
Mazdutide is ideal for male and female bodybuilders aged 21–40 in cutting cycles, seeking fat loss, improved metabolic health, and muscle preservation. It's suitable for intermediate to advanced users aiming for a lean physique without hormonal disruption. Not for: Individuals under 21, those with severe gastrointestinal issues, or those not under medical supervision. Regular blood work to monitor glucose and lipid levels is recommended.
How to Use
Dosage: Typical dosage is 3–9 mg/week (0.3–0.9 ml), administered once weekly via subcutaneous injection (e.g., abdomen). Start at 3 mg/week, increasing gradually to assess tolerance. Women may use similar doses under medical supervision.
Administration: Inject using a 0.5-inch insulin syringe (27–30G) in the stomach area. Administer at the same time weekly, ideally pre-workout or morning for consistency. Cycles typically last 12–24 weeks, aligned with fat loss goals.
Results Timeline: Fat loss and energy improvements are noticeable within 2–4 weeks, with significant weight reduction (7–15%) and improved body composition by 12–24 weeks when paired with a calorie-controlled diet and exercise.
Stacking Suggestions
Mazdutide is effective standalone but can be stacked for enhanced results:
- Cutting Stack: Combine with L-Carnitine (500–2000 mg/day) for amplified fat oxidation.
- Metabolic Stack: Pair with Cardarine (10–20 mg/day) for endurance and fat loss synergy.
- Support: Use with metformin (500–1000 mg/day, if prescribed) for enhanced glucose control.
Side Effects
Mazdutide is generally well-tolerated but may cause:
- Gastrointestinal: Nausea, diarrhea, vomiting, or abdominal bloating, typically mild and transient.
- Injection Site Reactions: Redness or irritation; rotate sites.
- Other: Upper respiratory infections, decreased appetite, or elevated liver enzymes (rare).
- Hormonal: No testosterone suppression, as it's non-androgenic.
Mazdutide is not hepatotoxic, but monitor liver function and glucose levels with prolonged use.
Post Cycle Therapy (PCT)
Mazdutide does not suppress testosterone or hormones, so PCT is not required. If stacked with anabolic steroids, follow standard PCT protocols (e.g., Clomid 50 mg/day, Nolvadex 20–40 mg/day for 4–6 weeks). Mazdutide can be continued during PCT to support fat loss and energy.
Frequently Asked Questions
What is Mazdutide?
Mazdutide is a dual GLP-1 and glucagon receptor agonist, a synthetic peptide mimicking oxyntomodulin, designed for fat loss, glycemic control, and metabolic health in obesity and type 2 diabetes research.
What are the benefits of taking Mazdutide?
Benefits include significant fat loss (up to 15.4% in 24 weeks), improved glycemic control (HbA1c reduction up to 1.7%), enhanced energy expenditure, and better cardiometabolic health (blood pressure, lipids, liver fat).
What are the results of Mazdutide?
Clinical trials show Mazdutide achieves 7–15.4% weight loss in 24 weeks, reduces HbA1c by up to 1.7%, lowers waist circumference, and improves lipid profiles and insulin sensitivity, with results peaking at 12–24 weeks.
What is Mazdutide used for?
Mazdutide is used for weight management, glycemic control in type 2 diabetes, and improving metabolic health, particularly in bodybuilding for fat loss and muscle preservation during cutting cycles.